Del Rosso has served as an investigator, consultant, advisor, and/or speaker for Galderma, Abbvie, Aclaris, Almirall, Amgen, Anaptys Bio, Arcutis, Athenex, Bausch, Biofrontera, Biopharmx, Biorasi, Blue Creek, Botanix, Brickell, Bristol Meyers Squibb, Cara Therapeutics, Cassiopea, Dermata, Dermavant, Encore, Epi Health, Evommune, Ferndale, Genentech, Incyte, JEM Health, Leo Pharma, La Roche Posay, Lilly, MC2, Novan, Pfizer, Ralexar, Regeneron, Sanofi-Genzyme, Sente, SolGel, Sonoma, Sun Pharma, Trevi, UCB, Verrica, and Vyne
Save your cinnamon for the kitchen
The latest and most effective of the class of drugs is Mounjaro, which helps patients achieve an average of around 20% body weight loss, vs ~14% with Ozempic
Eli Lilly's savings card can bring the price down to $25 per month for eligible patients
Visible weight loss typically becomes noticeable between weeks 4 and 8, then gradually increases over the following months as the dose increases